Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-25 @ 5:19 AM
NCT ID:
NCT03378427
Eligibility Criteria:
Inclusion Criteria:
* Patient at least 18 years;
* Orthopedic device infection defined according to the French recommendations published in 2009 (Med Mal Infect 2009; 39:745-774) for which TEDIZOLID treatment is proposed according to the investigator's decision;
* Bacterial documentation of the infection will only be based on the results of reliable samples such as joint aspiration and peroperative samples.
* Requiring TEDIZOLID administration as a single antibiotic therapy or in combination therapy including another agent with proven activity against the involved pathogen(s);
* No contraindication to TEDIZOLID;
* Provide a signed informed consent for the trial.
Exclusion Criteria:
* pregnant women or of childbearing age without contraception, breastfeeding,
* intolerance to TEDIZOLID;
* allergy to LINEZOLID;
* bactéria non susceptible to TEDIZOLID;
* patient with uncertainty regarding the possibility to achieve one-year follow-up after the end of treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03378427
Study Brief:
Protocol Section:
NCT03378427